| Become an Advocate
The Epilepsy Foundation of Louisiana has an active grassroots advocacy network where consumers effect change in the social service delivery system at the local, state, and national levels. Development of services are provided by individual advocacy and systems advocacy.
HAVE YOU MET AMY? If you haven't it's time you get to know Amy Nicols the advocacy coordinator for the state. Amy puts out a monthly advocacy alert to the community on advocacy issues both locally and nationally. If you are not receiving Amy's advocacy alerts click on the following link to begin receiving them. Receive Advocacy Alerts. If you would like to get involved in the Epilepsy Foundation's advocacy efforts email Amy: amy@epilepsylouisiana.org Read Amy's past Advocacy Alerts:
|
Find Your Congressional Leaders
|
Advocacy, Anti-Seizure Medication & You This year, 2007, marked the first attempt by the Epilepsy Foundation of Louisiana to support the passing of a House bill designed to protect the rights of Louisiana Residents with epilepsy. The Patient Protection Act was designed to require that all persons taking anti-epileptic medications and their doctors be fully informed before any change is made to the formulation of their medications. We at the Epilepsy Foundation strongly supported this legislation because many people have reported a change in their seizure status when the formulation of their medication has been changed. People from across the state were sought out to begin a grass roots advocacy initiative designed to support this legislation and an advocacy training session this past March. Unfortunately, the Patient Protection Act did not make it out of the Senate Health & Welfare committee this session. We are saddened by this turn of events but we are not giving up the fight. Our efforts to support such legislation and to encourage grass roots advocacy for the rights of individuals with epilepsy in Louisiana will continue in the future (more).
|
|
Report breakthrough seizures that occur after a change from one medication formulation to another to the following:
|
|